HF
IH

HRT Financial’s iHuman IH Stock Holding History

HRT Financial’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-18,387
Closed -$38K – 3067
2025
Q1 		$38K Buy
+18,387
New +$36.7K ﹤0.01% 2259

Other funds holding IH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

HRT Financial's IH Position: Q2 2025 in Review

HRT Financial sold out of iHuman (IH) in Q2 2025, closing a stake of 18,387 shares — an estimated $38K sold.

HRT Financial first reported a position in IH in Q1 2025 and held it in 1 quarter. The position peaked at $38K in Q1 2025. 9 funds tracked by Wall St. Rank hold IH as of Q2 2025.

  • HRT Financial reported no remaining iHuman position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 18,387 iHuman shares in Q2 2025, an estimated $38K.
  • HRT Financial first reported a position in iHuman in Q1 2025 and held it in 1 quarter.
  • HRT Financial's iHuman position peaked at $38K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held iHuman as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.